NervGen Pharma Corp. (NGEN) — Financial Flexibility Index
NervGen Pharma Corp. (NGEN) has a Financial Flexibility Index of -0.51x as of December 2025. Free cash flow of $-10.13 Million (operating CF $-10.13 Million minus capex $0.00) represents -1% of total liabilities ($19.73 Million). Also explore net asset growth rate of NervGen Pharma Corp. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NervGen Pharma Corp. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for NervGen Pharma Corp. across 8 annual periods. Check NGEN strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for NervGen Pharma Corp. (2018–2025)
Year-by-year free cash flow to debt coverage for NervGen Pharma Corp.. For the full company profile including market capitalisation, see NervGen Pharma Corp. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.99x | $-19.50 Million | $-19.50 Million | $19.73 Million | ▲ +0.8% |
| 2024 | -1.00x | $-11.70 Million | $-11.70 Million | $11.75 Million | ▼ -34.5% |
| 2023 | -0.74x | $-8.52 Million | $-8.52 Million | $11.50 Million | ▲ +56.6% |
| 2022 | -1.71x | $-13.10 Million | $-13.12 Million | $7.68 Million | ▲ +77.8% |
| 2021 | -7.67x | $-6.54 Million | $-6.54 Million | $852.33K | ▲ +8.2% |
| 2020 | -8.35x | $-4.95 Million | $-4.95 Million | $592.68K | ▲ +4.7% |
| 2019 | -8.76x | $-6.24 Million | $-6.24 Million | $712.51K | ▼ -391.1% |
| 2018 | -1.78x | $-761.52K | $-761.52K | $426.93K | — |